Literature DB >> 23600834

Paediatric Crohn disease patients with stricturing behaviour exhibit ileal granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibody production and reduced neutrophil bacterial killing and GM-CSF bioactivity.

I Jurickova1, M H Collins, C Chalk, A Seese, R Bezold, K Lake, D von Allmen, J S Frischer, R A Falcone, B C Trapnell, L A Denson.   

Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibodies are associated with stricturing behaviour in Crohn disease (CD). We hypothesized that CD ileal lamina propria mononuclear cells (LPMC) would produce GM-CSF autoantibodies and peripheral blood (PB) samples would contain GM-CSF neutralizing capacity (NC). Paediatric CD and control PBMC and ileal biopsies or LPMC were isolated and cultured and GM-CSF, immunoglobulin (Ig)G and GM-CSF autoantibodies production were measured by enzyme-linked immunosorbent assay (ELISA). Basal and GM-CSF-primed neutrophil bacterial killing and signal transducer and activator of transcription 5 (STAT5) tyrosine phosphorylation (pSTAT5) were measured by flow cytometry. GM-CSF autoantibodies were enriched within total IgG for LPMC isolated from CD ileal strictures and proximal margins compared to control ileum. Neutrophil bacterial killing was reduced in CD patients compared to controls. Within CD, neutrophil GM-CSF-dependent STAT5 activation and bacterial killing were reduced as GM-CSF autoantibodies increased. GM-CSF stimulation of pSTAT5 did not vary between controls and CD patients in washed PB granulocytes in which serum was removed. However, GM-CSF stimulation of pSTAT5 was reduced in whole PB samples from CD patients. These data were used to calculate the GM-CSF NC. CD patients with GM-CSF NC greater than 25% exhibited a fourfold higher rate of stricturing behaviour and surgery. The likelihood ratio (95% confidence interval) for stricturing behaviour for patients with elevation in both GM-CSF autoantibodies and GM-CSF NC was equal to 5 (2, 11). GM-CSF autoantibodies are produced by LPMC isolated from CD ileal resection specimens and are associated with reduced neutrophil bacterial killing. CD peripheral blood contains GM-CSF NC, which is associated with increased rates of stricturing behaviour.
© 2013 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23600834      PMCID: PMC3646445          DOI: 10.1111/cei.12076

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Sargramostim for active Crohn's disease.

Authors:  Joshua R Korzenik; Brian K Dieckgraefe; John F Valentine; Diana F Hausman; Mark J Gilbert
Journal:  N Engl J Med       Date:  2005-05-26       Impact factor: 91.245

2.  STAT3 genotypic variation and cellular STAT3 activation and colon leukocyte recruitment in pediatric Crohn disease.

Authors:  Tara A Willson; Benjamin R Kuhn; Ingrid Jurickova; Shaina Gerad; David Moon; Erin Bonkowski; Rebecca Carey; Margaret H Collins; Huan Xu; Anil G Jegga; Stephen L Guthery; Lee A Denson
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-07       Impact factor: 2.839

3.  Defective leukocyte GM-CSF receptor (CD116) expression and function in inflammatory bowel disease.

Authors:  Jonathan I Goldstein; Douglas J Kominsky; Nicole Jacobson; Brittelle Bowers; Kirsten Regalia; Gregory L Austin; Melinda Yousefi; Michael T Falta; Andrew P Fontenot; Mark E Gerich; Lucy Golden-Mason; Sean P Colgan
Journal:  Gastroenterology       Date:  2011-04-07       Impact factor: 22.682

4.  Granulocyte macrophage-colony-stimulating factor autoantibodies and increased intestinal permeability in Crohn disease.

Authors:  Cade M Nylund; Sharon D'Mello; Mi-Ok Kim; Erin Bonkowski; Jan Däbritz; Dirk Foell; Jon Meddings; Bruce C Trapnell; Lee A Denson
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-05       Impact factor: 2.839

5.  Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease.

Authors:  Xiaonan Han; Kanji Uchida; Ingrid Jurickova; Diana Koch; Tara Willson; Charles Samson; Erin Bonkowski; Anna Trauernicht; Mi-Ok Kim; Gitit Tomer; Marla Dubinsky; Scott Plevy; Subra Kugathsan; Bruce C Trapnell; Lee A Denson
Journal:  Gastroenterology       Date:  2008-12-24       Impact factor: 22.682

6.  Patients with inflammatory bowel disease may have a transforming growth factor-beta-, interleukin (IL)-2- or IL-10-deficient state induced by intrinsic neutralizing antibodies.

Authors:  E C Ebert; A Panja; K M Das; R Praveen; X Geng; C Rezac; M Bajpai
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

7.  Non-response to infliximab may be due to innate neutralizing anti-tumour necrosis factor-alpha antibodies.

Authors:  E C Ebert; K M Das; V Mehta; C Rezac
Journal:  Clin Exp Immunol       Date:  2008-09-23       Impact factor: 4.330

8.  GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis.

Authors:  Kanji Uchida; David C Beck; Takashi Yamamoto; Pierre-Yves Berclaz; Shuichi Abe; Margaret K Staudt; Brenna C Carey; Marie-Dominique Filippi; Susan E Wert; Lee A Denson; Jonathan T Puchalski; Diane M Hauck; Bruce C Trapnell
Journal:  N Engl J Med       Date:  2007-02-08       Impact factor: 91.245

9.  Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease.

Authors:  Rebecca Carey; Ingrid Jurickova; Edgar Ballard; Erin Bonkowski; Xiaonan Han; Huan Xu; Lee A Denson
Journal:  Inflamm Bowel Dis       Date:  2008-04       Impact factor: 5.325

10.  Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis.

Authors:  Satheesh K Sainathan; Eyad M Hanna; Qingqing Gong; Kumar S Bishnupuri; Qizhi Luo; Marco Colonna; Frances V White; Ed Croze; Courtney Houchen; Shrikant Anant; Brian K Dieckgraefe
Journal:  Inflamm Bowel Dis       Date:  2008-01       Impact factor: 5.325

View more
  11 in total

1.  Genetic and Transcriptomic Variation Linked to Neutrophil Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Pediatric Crohn's Disease.

Authors:  Lee A Denson; Ingrid Jurickova; Rebekah Karns; Kelly A Shaw; David J Cutler; David Okou; C Alexander Valencia; Anne Dodd; Kajari Mondal; Bruce J Aronow; Yael Haberman; Aaron Linn; Adam Price; Ramona Bezold; Kathleen Lake; Kimberly Jackson; Thomas D Walters; Anne Griffiths; Robert N Baldassano; Joshua D Noe; Jeffrey S Hyams; Wallace V Crandall; Barbara S Kirschner; Melvin B Heyman; Scott Snapper; Stephen L Guthery; Marla C Dubinsky; Neal S Leleiko; Anthony R Otley; Ramnik J Xavier; Christine Stevens; Mark J Daly; Michael E Zwick; Subra Kugathasan
Journal:  Inflamm Bowel Dis       Date:  2019-02-21       Impact factor: 5.325

2.  Familial Association of Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Inflammatory Bowel Disease.

Authors:  Sandra S Wright; Anna Trauernicht; Erin Bonkowski; Courtney A McCall; Elizabeth A Maier; Ramona Bezold; Kathleen Lake; Claudia Chalk; Bruce C Trapnell; Mi-Ok Kim; Subra Kugathasan; Lee A Denson
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-05       Impact factor: 2.839

3.  Clinical and Genomic Correlates of Neutrophil Reactive Oxygen Species Production in Pediatric Patients With Crohn's Disease.

Authors:  Lee A Denson; Ingrid Jurickova; Rebekah Karns; Kelly A Shaw; David J Cutler; David T Okou; Anne Dodd; Kathryn Quinn; Kajari Mondal; Bruce J Aronow; Yael Haberman; Aaron Linn; Adam Price; Ramona Bezold; Kathleen Lake; Kimberly Jackson; Thomas D Walters; Anne Griffiths; Robert N Baldassano; Joshua D Noe; Jeffrey S Hyams; Wallace V Crandall; Barbara S Kirschner; Melvin B Heyman; Scott Snapper; Stephen L Guthery; Marla C Dubinsky; Neal S Leleiko; Anthony R Otley; Ramnik J Xavier; Christine Stevens; Mark J Daly; Michael E Zwick; Subra Kugathasan
Journal:  Gastroenterology       Date:  2018-02-15       Impact factor: 22.682

4.  Recruitment of activated neutrophils correlates with disease severity in adult Crohn's disease.

Authors:  A Therrien; L Chapuy; M Bsat; M Rubio; G Bernard; E Arslanian; K Orlicka; A Weber; B-P Panzini; J Dorais; E-J Bernard; G Soucy; M Bouin; M Sarfati
Journal:  Clin Exp Immunol       Date:  2018-11-28       Impact factor: 4.330

5.  GM-CSF and the role of myeloid regulatory cells in the pathogenesis and treatment of Crohn's disease.

Authors:  Jan Däbritz
Journal:  Mol Cell Pediatr       Date:  2015-12-01

6.  Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.

Authors:  Dominik Bettenworth; Florian Rieder
Journal:  Fibrogenesis Tissue Repair       Date:  2014-03-29

7.  Impaired granulocyte-macrophage colony-stimulating factor bioactivity accelerates surgical recurrence in ileal Crohn's disease.

Authors:  Grace Gathungu; Yuanhao Zhang; Xinyu Tian; Erin Bonkowski; Leahana Rowehl; Julia Krumsiek; Billy Nix; Claudia Chalk; Bruce Trapnell; Wei Zhu; Rodney Newberry; Lee Denson; Ellen Li
Journal:  World J Gastroenterol       Date:  2018-02-07       Impact factor: 5.742

8.  GM-CSF Calibrates Macrophage Defense and Wound Healing Programs during Intestinal Infection and Inflammation.

Authors:  Tomas Castro-Dopico; Aaron Fleming; Thomas W Dennison; John R Ferdinand; Katherine Harcourt; Benjamin J Stewart; Zaeem Cader; Zewen K Tuong; Chenzhi Jing; Laurence S C Lok; Rebeccah J Mathews; Anaïs Portet; Arthur Kaser; Simon Clare; Menna R Clatworthy
Journal:  Cell Rep       Date:  2020-07-07       Impact factor: 9.423

9.  Pulmonary Alveolar Proteinosis with Ulcerative Colitis.

Authors:  Noriho Sakamoto; Shota Nakashima; Hiroshi Ishimoto; Tomoyuki Kakugawa; Atsuko Hara; Hirokazu Yura; Takuto Miyamura; Seiko Nakamichi; Yasushi Obase; Yuji Ishimatsu; Hiroshi Mukae
Journal:  Intern Med       Date:  2018-04-27       Impact factor: 1.271

10.  Neutrophil GM-CSF signaling in inflammatory bowel disease patients is influenced by non-coding genetic variants.

Authors:  Suresh Venkateswaran; Lee A Denson; Ingrid Jurickova; Anne Dodd; Michael E Zwick; David J Cutler; Subra Kugathasan; David T Okou
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.